Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Michele R. Wing, Julie W. Reeser, Amy M. Smith, Matthew Reeder, Dorrelyn Martin, Benjamin M. Jewell, Jharna Datta, Jharna Miya, J. Paul Monk, Amir Mortazavi, Gregory A. Otterson, Richard M. Goldberg, Jeffrey B. VanDeusen, Sharon Cole, Kristin Dittmar, Sunny Jaiswal, Matthew Kinzie, Suraj Waikhom, Aharon G. Freud, Xiao-Ping Zhou, Wei Chen, Darshna Bhatt, Sameek Roychowdhury
Published Sep 1, 2017 · Vol. 8, No. 44 · pp. 75822-75833
Laura Jacobs, Stefan Habringer, Jolanta Slawska, Katharina Huber, Elke Hauf, Zhoulei Li, Yosef Refaeli, Markus Schwaiger, Martina Rudelius, Axel Walch, Ulrich Keller
Published Aug 24, 2017 · Vol. 8, No. 45 · pp. 78917-78929
